Literature DB >> 6409062

Clinical and EEG estimates of absence seizure frequency.

T R Browne, F E Dreifuss, J K Penry, R J Porter, B G White.   

Abstract

Absence seizure frequency was estimated in 20 patients (5 to 15 years old) before and after treatment with ethosuximide. Estimates were obtained from mothers' histories, observations by nurses, intensive observation by trained observers, physical and neurological examinations, routine EEG, and 12-hour telemetered EEG. Both before treatment (high seizure frequency) and after treatment (low frequency), telemetered EEG was the most reliable method of estimation, and intensive observation was the next best method. After treatment, the mothers' and nurses' estimates of seizure frequency were significantly less than the telemetered EEG estimates. The neurological examination and routine EEG were sufficient to diagnose absence attacks in all 20 patients and to determine if the attacks were completely controlled by therapy in all but two patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409062     DOI: 10.1001/archneur.1983.04210070009004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Peter C Adamson
Journal:  Epilepsia       Date:  2012-11-21       Impact factor: 5.864

2.  Absence Seizure Detection Algorithm for Portable EEG Devices.

Authors:  Pawel Glaba; Miroslaw Latka; Małgorzata J Krause; Sławomir Kroczka; Marta Kuryło; Magdalena Kaczorowska-Frontczak; Wojciech Walas; Wojciech Jernajczyk; Tadeusz Sebzda; Bruce J West
Journal:  Front Neurol       Date:  2021-06-29       Impact factor: 4.003

3.  Lamotrigine monotherapy for newly diagnosed typical absence seizures in children.

Authors:  Gregory L Holmes; L Matthew Frank; Raj D Sheth; Bryan Philbrook; John D Wooten; Alain Vuong; Susan Kerls; Anne E Hammer; John Messenheimer
Journal:  Epilepsy Res       Date:  2008-09-07       Impact factor: 3.045

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.